Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Rupture, Spontaneous

imatinib mesylate has been researched along with Rupture, Spontaneous in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's10 (90.91)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Zhou, YB1
Bjerkehagen, B; Boye, K; Bruland, ØS; Hall, KS; Hompland, I; Hølmebakk, T; Stoldt, S1
Cao, LL; Chen, QY; Dai, Y; Huang, CM; Huang, ZN; Li, P; Lin, JL; Lin, JX; Lin, M; Lu, J; Tu, RH; Wang, JB; Xie, JW; Zheng, CH; Zheng, HL1
Kirii, Y; Misawa, S; Ota, H; Sakamoto, H; Takagi, H; Takeda, M1
Chung, KM; Lai, EC; Lau, SH; Lau, WY1
Chang, YR; Han, IW; Jang, JY; Kang, MJ; Kim, SW; Kwon, W; Lee, HJ; Lee, KB; Park, JW; Park, KJ1
Ha, HK; Kim, AY; Kim, HJ; Kim, JS; Lee, JS; Park, SH1
Bylina, E; Głuszek, S; Joensuu, H; Kroc, J; Matlok, M; Michej, W; Nasierowska-Guttmejer, A; Nowecki, ZI; Osuch, C; Rutkowski, P; Switaj, T; Wozniak, A; Wroński, M1
Cubedo, R; Quintero, CB1
de Juan Ferré, A; Fernández, F; Garicano, F; Gutiérrez, L; Malaxetxebarria, S1
del Muro, XG; López, RL1

Reviews

2 review(s) available for imatinib mesylate and Rupture, Spontaneous

ArticleYear
Spontaneous rupture of a giant gastrointestinal stromal tumor of the jejunum: a case report and literature review.
    World journal of surgical oncology, 2014, May-21, Volume: 12

    Topics: Aged; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Male; Peritoneal Neoplasms; Piperazines; Prognosis; Pyrimidines; Rupture, Spontaneous; Tomography, X-Ray Computed

2014
Management of localized gastrointestinal stromal tumors and adjuvant therapy with imatinib.
    Anti-cancer drugs, 2012, Volume: 23 Suppl

    Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Mitotic Index; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Risk; Rupture, Spontaneous

2012

Other Studies

9 other study(ies) available for imatinib mesylate and Rupture, Spontaneous

ArticleYear
[Definition of tumor rupture in gastrointestinal stromal tumor].
    Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2021, Sep-25, Volume: 24, Issue:9

    Topics: Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rupture, Spontaneous

2021
Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study.
    Annals of surgical oncology, 2018, Volume: 25, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Mitotic Index; Neoadjuvant Therapy; Retrospective Studies; Risk Assessment; Rupture, Spontaneous; Stomach Neoplasms; Young Adult

2018
What is the appropriate duration of adjuvant imatinib mesylate treatment for primary gastrointestinal stromal tumors classified according to the strict definition of tumor rupture?
    Medicine, 2019, Volume: 98, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Prognosis; Retrospective Studies; Rupture, Spontaneous; Survival Rate; Treatment Outcome; Young Adult

2019
A ruptured recurrent small bowel gastrointestinal stromal tumour causing hemoperitoneum.
    Frontiers of medicine, 2015, Volume: 9, Issue:1

    Topics: Antineoplastic Agents; Benzamides; Cytoreduction Surgical Procedures; Disease Progression; Dissection; Dose-Response Relationship, Drug; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hemoperitoneum; Humans; Imatinib Mesylate; Intestine, Small; Male; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Postoperative Complications; Pyrimidines; Risk Assessment; Rupture, Spontaneous

2015
Clinicopathologic analysis of gastrointestinal stromal tumors in duodenum and small intestine.
    World journal of surgery, 2015, Volume: 39, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Mitotic Index; Neoplasm Staging; Piperazines; Pyrimidines; Retrospective Studies; Rupture, Spontaneous; Survival Analysis; Survival Rate; Young Adult

2015
Computed tomography features and predictive findings of ruptured gastrointestinal stromal tumours.
    European radiology, 2017, Volume: 27, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Ascites; Disease Progression; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hematoma; Hemoperitoneum; Humans; Imatinib Mesylate; Indoles; Intestine, Small; Male; Middle Aged; Necrosis; Peritonitis; Pyrroles; Rupture, Spontaneous; Sensitivity and Specificity; Sunitinib; Tomography, X-Ray Computed; Young Adult

2017
Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2011, Volume: 37, Issue:10

    Topics: Adolescent; Adult; Aged, 80 and over; Benzamides; Chemotherapy, Adjuvant; Child; Disease-Free Survival; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Piperazines; Practice Guidelines as Topic; Proportional Hazards Models; Pyrimidines; Registries; Retrospective Studies; Risk Assessment; Rupture, Spontaneous; Statistics, Nonparametric; Survival Analysis; Treatment Outcome; Tumor Burden; Young Adult

2011
Tumor rupture exposes the patient to an increased risk of relapse, regardless of the size and number of mitoses.
    Anti-cancer drugs, 2012, Volume: 23 Suppl

    Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intraoperative Complications; Mitotic Index; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Risk; Rupture, Spontaneous

2012
Haemoperitoneum as an indicator of GIST.
    Anti-cancer drugs, 2012, Volume: 23 Suppl

    Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hemoperitoneum; Humans; Imatinib Mesylate; Middle Aged; Piperazines; Pyrimidines; Rupture, Spontaneous; Tomography, X-Ray Computed; Treatment Outcome

2012